| Hillcrest Health & Rehab | |
| 1702 Hillcrest Drive, Bellevue, Nebraska 68005 | |
| (402) 291-8500 | |
| Name | Hillcrest Health & Rehab |
|---|---|
| Location | 1702 Hillcrest Drive, Bellevue, Nebraska |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 151 |
| Occupancy Rate | 73.05% |
| Medicare ID (CCN) | 285133 |
| Legal Business Name | Red Oak Health Services Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1275671794 |
| Organization Name | RED OAK HEALTH SERVICES INC |
| Doing Business As | HILLCREST HEALTH & REHAB |
| Address | 1702 Hillcrest Dr, Bellevue, NE 68005 |
| Phone Number | 402-291-8500 |
News Archive
A new study has found a "significant association" between adults who have suffered a traumatic brain injury at some point in their lives and who also have attention deficit hyperactive disorder.
News organizations outline changes to Medicaid programs in New York - where proposed changes hinge on a decision in Washington - and Pennsylvania - where up to 100,000 households' Medicaid coverage could be reinstated after being purged from the rolls.
Though the U.S. and South Korea recorded their first official COVID-19 case on the same day, January 20, 2020, there were notable differences in how each country would ultimately address what has become the world's most severe pandemic since 1918.
Micromet, Inc. today announced the presentation of updated results from a Phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with minimal residual disease (MRD) positive acute lymphoblastic leukemia (ALL). Results of the analysis demonstrate that a prolonged hematologic relapse free survival was observed in patients treated with blinatumomab.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new study has found a "significant association" between adults who have suffered a traumatic brain injury at some point in their lives and who also have attention deficit hyperactive disorder.
News organizations outline changes to Medicaid programs in New York - where proposed changes hinge on a decision in Washington - and Pennsylvania - where up to 100,000 households' Medicaid coverage could be reinstated after being purged from the rolls.
Though the U.S. and South Korea recorded their first official COVID-19 case on the same day, January 20, 2020, there were notable differences in how each country would ultimately address what has become the world's most severe pandemic since 1918.
Micromet, Inc. today announced the presentation of updated results from a Phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with minimal residual disease (MRD) positive acute lymphoblastic leukemia (ALL). Results of the analysis demonstrate that a prolonged hematologic relapse free survival was observed in patients treated with blinatumomab.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $35350 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 11.48 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 16.13 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 50.6 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.82 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.9 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.9 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.36 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.31 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.73 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94.39 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.11 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 31.6 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.85 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.98 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.83 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 62.57 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 81.28 | 82.93 |
News Archive
A new study has found a "significant association" between adults who have suffered a traumatic brain injury at some point in their lives and who also have attention deficit hyperactive disorder.
News organizations outline changes to Medicaid programs in New York - where proposed changes hinge on a decision in Washington - and Pennsylvania - where up to 100,000 households' Medicaid coverage could be reinstated after being purged from the rolls.
Though the U.S. and South Korea recorded their first official COVID-19 case on the same day, January 20, 2020, there were notable differences in how each country would ultimately address what has become the world's most severe pandemic since 1918.
Micromet, Inc. today announced the presentation of updated results from a Phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with minimal residual disease (MRD) positive acute lymphoblastic leukemia (ALL). Results of the analysis demonstrate that a prolonged hematologic relapse free survival was observed in patients treated with blinatumomab.
› Verified 2 days ago
Hillcrest Health & Rehab Location: 1702 Hillcrest Drive, Bellevue, Nebraska 68005 Phone: (402) 291-8500 |